Loading company…
Houston-based MolecularMatch sells a subscription clinical informatics platform for precision oncology treatment recommendations.
Founded in 2014 by James Welsh and Nick Tackes, MolecularMatch is headquartered in Houston, US. Its platform uses Natural Language Processing and machine learning to generate evidence-based treatment reports for health and life science organizations. Products include MMPower and MMPortal. Ut Horizon Fund acquired the company in July 2017, and it has completed one known funding deal.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in